FDA strengthens warning on prescription anti-inflammatory medications

A decade's worth of research on nonsteroidal anti-inflammatory drugs, or NSAIDs,  has prompted the Food and Drug Administration to demand stiffer warnings on the labels of such prescription medications as celecoxib (marketed commercially as Celebrex) and diclofenac (Voltaren) about the increased...

via L.A. Times - Science http://ift.tt/1Hg5FFh